PDF-Jubilant Life Sciences
Noida Mon
day July
2
0 20
20
Limited announces approval
of JUBI R remdesivir
in India for the treatment of C
OVID 19
Jubilant Life Sciences Limited an integrated
Download Presentation
Download Note : "Jubilant Life Sciences" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.